Advanced Search

Oncology & Hematology Coding Alert

You Be the Coder:

Code Olaratumab as Unlisted

Published on Tue Feb 14, 2017

Question: Our physician prescribed olaratumab for a patient diagnosed with soft tissue sarcoma. Is this an approved therapy for this condition? How can we report for this therapy? New York Subscriber Answer: Olaratumab is approved for the treatment of soft tissue sarcoma. On October 19, 2016, the FDA granted an accelerated approval to olaratumab for the treatment of adults with certain types [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All